Results 181 to 190 of about 27,554,683 (360)

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Temporal patterns of motor and nonmotor symptom emergence in Parkinson's disease: a cluster analysis. [PDF]

Clin Park Relat Disord
Sugimura Y, Baba T, Totsune T, Oizumi H, Hasegawa T, Suzuki K, Takeda A.   +6 more
europepmc   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Intention to Use Digital Health Among COPD Patients in Europe: A Cluster Analysis. [PDF]

Healthcare (Basel)
Alem SG, Nguyen L, Hipólito N, Spiller M, Metting E.   +4 more
europepmc   +1 more source

Analysis of The Core Industry Determination of Cassava-Based Industrial Clusters Development in Jember Regency

Emi Kurniawati, Yani Subaktilah
openalex   +2 more sources

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Cluster Analysis to Identify Distinct Asthma Phenotypes in the ATLANTIS Cohort. [PDF]

Allergy
Kuks PJM, Karp T, Hartman JE, Kraft M, Siddiqui S, Fabbri LM, Beghé B, Rabe KF, Papi A, Brightling CE, Singh D, Li X, Kocks JWH, Scaffidi-Argentina U, Kerstjens HAM, Heijink IH, Pouwels SD, Slebos DJ, van den Berge M.   +18 more
europepmc   +1 more source

Social Media Use and Depression and Anxiety Symptoms: A Cluster Analysis.

American Journal of Health Behavior, 2018
A. Shensa, J. Sidani, M. Dew, César G. Escobar-Viera, B. Primack   +4 more
semanticscholar   +1 more source

Crucial parameters for precise copy number variation detection in formalin‐fixed paraffin‐embedded solid cancer samples

Molecular Oncology, EarlyView.
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris, Vasiliki Siozopoulou, Léon C van Kempen, Anne Sieben, Ella Roelant, Stig Hellemans, Elyne Backx, Laure Sorber, Koen De Winne, Senada Koljenović, Karen Zwaenepoel   +10 more
wiley   +1 more source

Hypertension Phenotypes and Mortality Risk in the United States of America: A Data-Driven Cluster Analysis. [PDF]

Int J Hypertens
Carrillo-Larco RM, Varghese JS, Quyyumi A, Narayan KMV, Wilson PWF, Ali MK.   +5 more
europepmc   +1 more source